Fang, Shunzheng
Zhang, Bin
Xiang, Wei
Zheng, Liujie
Wang, Xiaodong
Li, Song
Zhang, Tongyi
Feng, Daibo
Gong, Yunquan
Wu, Jinhui
Yuan, Jing
Wu, Yaran
Zhu, Yizhen
Liu, Enli
Ni, Zhenhong
Funding for this research was provided by:
National Natural Science Foundation of China (82372495, 82202770)
Natural Science Foundation of Chongqing (CSTB2022NSCQ-MSX1267, CSTB2022NSCQ-MSX0863)
Natural Science Foundation of Shanxi Province (20210302123318)
Open Fund of Shanxi Key Laboratory of Innovative Drug for the Treatment of Serious Diseases Basing on the Chronic Inflammation, Shanxi University of Chinese Medicine (2021sxcxyw08)
Article History
Received: 21 November 2023
Accepted: 5 February 2024
First Online: 15 February 2024
Declarations
:
: Not applicable.
: All authors reviewed the final version of the manuscript and approved it for publication.
: The authors declare that there are no personal, organizational, or financial conflicts of interest.